FRMD6 and Hepatic fibrosis: Li et al. found that lncRNA FRMD6-AS1 inhibits HSC ferroptosis through negative regulation of the miR-491-5p/USP13 pathway in both in vitro and in vivo models, promoting ECM deposition and advancing liver fibrosis.